Infinity Bio, Inc.
PrivateLast Round
Series A
Jun 18, 2025
Total Funding Raised
$8M
Momentum Score
25 /100
Company Overview
Infinity Bio, Inc. is a biotechnology company that provides detailed insights into the immune system using its proprietary antibody reactome profiling platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Infinity Bio, Inc. Comps
Public and private peers based on sector, stage, and business model.
Infinity Bio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 18, 2025 |
Key People
Founding team and executive leadership
Infinity Bio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| PTX Capital | Series A |
| Illumina Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 20, 2026
Monthly visitors increased 87% MoM.
- Jun 18, 2025
$8M round completed.
Infinity Bio, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Infinity Bio, Inc.'s valuation, stock price, and market status.
